NCT04367740View on ClinicalTrials.gov

ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19

CompletedOBSERVATIONAL
Enrollment

6,313

Participants

Timeline

Start Date

April 28, 2020

Primary Completion Date

February 24, 2022

Study Completion Date

February 28, 2022

Conditions
Asymptomatic ConditionInfection ViralCoronavirus InfectionsSevere Acute Respiratory Syndrome Coronavirus 2Coronaviridae InfectionsRNA Virus InfectionsVirus DiseasesCommunicable Disease
Interventions
DIAGNOSTIC_TEST

To assess for development of IgG antibodies against SARS-CoV2

Swabs will be collected to assess for COVID-19 if PPE supplies allow.

Trial Locations (1)

27599

Center for Environmental Medicine, Asthma and Lung Biology, Chapel Hill

All Listed Sponsors
lead

University of North Carolina, Chapel Hill

OTHER

NCT04367740 - ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19 | Biotech Hunter | Biotech Hunter